This issue represents a rather detailed look at the current state of blood and tumor tissue testing in prostate cancer. The PSA is the classic example against which new tests can be compared. The PSA … more

Three topics dominate this issue: the current status of the Provenge (sipuleucel-T) vaccine, the status of other immunotherapy techniques under development, and the use of poly ADP ribose polymerase ( … more

This issue marks a new era for this publication as it is the first to be published under the NASPCC umbrella. We anticipate that this will allow us to reach a much larger audience.

 As an old hand … more

This month we’re talking about” “imaging for prostate cancer.” “Imaging technology is advancing” “rapidly and is transforming” “both prostate cancer diagnosis” “and offering new insight into” “how … more

For men just diagnosed with prostate cancer, the threat treatment poses for sexual function looms large and can play a major role in which treatment they choose. It can even lead some men to choose … more

Many patients fear chemotherapy not only because of its side effects but also because of what the need for chemotherapy implies about their prognosis. Fortunately, each physician we spoke with this … more

This issue is devoted to the genetics and genomics of prostate cancer, which is one of the most promising and exciting areas of prostate cancer research. Already, this line of investigation is having … more

In June, we’re talking about ways in which you as a patient can benefit from and in turn contribute to the prostate cancer community. 

What do we mean by that? Chances are, when you were first told … more